← Leaderboards
Ralph E Parchment
Wayne State University
$1,893,148
Attributed
$1,893,148
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $127.4K · FY2005–09$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,893,148 · 6
By mechanism
P30$512,466 · 1
R44$507,307 · 1
R21$339,449 · 1
R43$293,979 · 2
R41$239,947 · 1
Top collaborators
No co-investigators on record.
Most similar at Wayne State University
Same institution · by research overlap
- Jing Li$1,544,474
- Larry H. Matherly$14,225,491
- Yaddanapudi Ravindranath$357,350
Others in their field
Top investigators on “Analog”
- David Heimbrook · Leidos Biomedical Research, Inc.$196,589,777
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Norman Wolmark · Nsabp Foundation, Inc.$51,982,954
- Robert Turner Schooley · University Of Colorado Denver$48,513,949
- Kenneth A Bloom · University Of Nebraska-Lincoln$46,979,168
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
AnalogDietary SupplementsNeoplasm /Cancer PharmacologyHigh Performance Liquid ChromatographyDose-LimitingChemopreventive AgentDrug InteractionsChemical StabilityData AnalysesCollectionChemotherapyClientCellular AssayBaseAdverse Drug EffectChemotherapy-Oncologic ProcedureCellsBone MarrowBiomedical FacilityBiopsyAreaBlindedAccountabilityClinical Trials
Grant awards (14)
Core--Pharmacology- Shared Resource$127,367
P30 · FY2009 · CA · contact PI
Core--Pharmacology- Shared Resource$127,187
P30 · FY2008 · CA · contact PI
Core--Pharmacology- Shared Resource$125,583
P30 · FY2007 · CA · contact PI
Core--Pharmacology- Shared Resource$67,143
P30 · FY2006 · CA · contact PI
Core--Pharmacology- Shared Resource$65,186
P30 · FY2005 · CA
Parenteral Formulations for Synthetic Retinoids$507,307
R44 · FY2004 · CA
In Vitro Cardiac Device for Assessing Proarrhythmic Risk$239,947
R41 · FY2004 · CA
Acute Toxicity in Renewing Tissues and In Vitro Data$163,744
R21 · FY2002 · CA
CORE--PHARMACOLOGY$0
P30 · FY2002 · CA
Acute Toxicity in Renewing Tissues and In Vitro Data$175,705
R21 · FY2001 · CA
Parenteral Formulations for Synthetic Retinoids$154,471
R43 · FY2001 · CA
STABLE STEREOISOMER ANALOGS OF TOPO IIBETA INHIBITORS$139,508
R43 · FY2001 · CA
CORE--PHARMACOLOGY$0
P30 · FY2001 · CA
CORE--PHARMACOLOGY$0
P30 · FY2001 · CA